Feed

24/06/2022
Stock­holm Ar­bit­ra­tion Tribunal Denies Jur­is­dic­tion over In­tra-EU In­vest­ment...
In a ground­break­ing award, dated 16 June 2022, made in Green Power Part­ners K/S and SCE Sol­ar Don Benito APS v The King­dom of Spain, a tribunal con­sti­tuted un­der the Ar­bit­ra­tion Rules of the Ar­bit­ra­tion...
20/06/2022
The United States Su­preme Court Re­stricts Dis­cov­ery for In­ter­na­tion­al Ar­bit­ra­tions
In a land­mark de­cision is­sued on 13 June 2022,[1] the US Su­preme Court (“SCOTUS”), Amer­ica’s highest court, ruled that the scope of Sec­tion 1782 of the United States Code (“U.S.C.”) does not...
15/06/2022
New fa­vor­able So­cial Se­cur­ity Policies is­sued for the epi­dem­ic in China
The re­sur­gence of the epi­dem­ic situ­ation in China caused lock­downs in sev­er­al cit­ies and im­pacted a lot of busi­nesses. To help com­pan­ies to over­come dif­fi­culties, in April and May 2022, the Chinese Gov­ern­ment...
13/06/2022
Up­dated CMS Ex­pert Guide to Trade Secrets
From pat­ents to pro­grammes, designs to data, your most valu­able busi­ness as­sets can be the things you can’t put un­der lock and key. But what leg­al re­course do you have to pro­tect these in­tan­gible as­sets...
08/06/2022
Chinese Tax Reg­u­la­tion Up­date | May 2022
The latest de­vel­op­ment in China Tax Reg­u­la­tion mainly in­cludes:  An­nounce­ment [2022] No. 18 jointly re­leased by the Min­istry of Fin­ance (“MOF”) and the State Ad­min­is­tra­tion of Tax­a­tion...
07/06/2022
Trade secret laws and reg­u­la­tions in Hong Kong
Gen­er­al 1. Has the Dir­ect­ive (EU) 2016/943 of the European Par­lia­ment and of the Coun­cil of 8 June 2016 on the pro­tec­tion of un­dis­closed know-how and busi­ness in­form­a­tion (trade secrets) against their...
Comparable
07/06/2022
Ad­verse ef­fects of drugs and vac­cines in Hong Kong
1. Drug ad­verse ef­fects: kinds of re­spons­ib­il­ity 1.1 Which are the main kinds of re­spons­ib­il­ity (con­trac­tu­al, in tort, crim­in­al) of the fol­low­ing sub­jects with re­spect to ad­verse drugs re­ac­tions? There...
Comparable
01/06/2022
CMS Next
What’s next? In a world of ever-ac­cel­er­at­ing change, stay­ing ahead of the curve and know­ing what’s next for your busi­ness or sec­tor is es­sen­tial.At CMS, we see ourselves not only as your leg­al ad­visers but also as your busi­ness part­ners. We work to­geth­er with you to not only re­solve cur­rent is­sues but to an­ti­cip­ate fu­ture chal­lenges and in­nov­ate to meet them.With our latest pub­lic­a­tion, CMS Next, our ex­perts will reg­u­larly of­fer you in­sights in­to and fresh per­spect­ives on a range of is­sues that busi­nesses have to deal with – from ESG agen­das to re­struc­tur­ing after the pan­dem­ic or fa­cing the di­git­al trans­form­a­tion. We will also share with you more about the work that we are do­ing for our cli­ents, help­ing them in­nov­ate, grow and mit­ig­ate risk.To be able to provide you with the best sup­port, we im­merse ourselves in your world to un­der­stand your leg­al needs and chal­lenges. However, it is equally im­port­ant that you know who we are and how we can work with you. So, we in­vite you to meet our ex­perts and catch a glimpse of what is hap­pen­ing in­side CMS.En­joy read­ing this pub­lic­a­tion, which we will up­date reg­u­larly with new con­tent.CMS Ex­ec­ut­ive Team
31/05/2022
Over­view of Loc­al­iz­a­tion Trend of Med­ic­al Devices
On 21 April 2022, the De­part­ment of Fin­ance of An­hui Province, the Health Com­mis­sion of An­hui Province and the Health­care Se­cur­ity Bur­eau of An­hui Province jointly is­sued the Cir­cu­lar on Reg­u­lat­ing Gov­ern­ment...
20/05/2022
Amended IC­SID Rules to enter in­to force on 1 Ju­ly 2022
On 21 March 2022, the Mem­ber States of the In­ter­na­tion­al Centre for Set­tle­ment of In­vest­ment Dis­putes (IC­SID) ad­op­ted a com­pre­hens­ive set of amend­ments to IC­SID ar­bit­ra­tion and con­cili­ation rules (“IC­SID...
16/05/2022
Re­lease of Draft Rules on Cer­ti­fic­a­tion for Cross-Bor­der Per­son­al Data...
On 29 April 2022, the Na­tion­al In­form­a­tion Se­cur­ity Stand­ard­isa­tion Tech­nic­al Com­mit­tee is­sued a draft of the Tech­nic­al Spe­cific­a­tions for Cer­ti­fic­a­tion of Per­son­al In­form­a­tion Cross-bor­der Pro­cessing...
16/05/2022
High­lights on Ad­min­is­trat­ive Pro­vi­sions on Drug An­nu­al Re­port­ing
The Na­tion­al Med­ic­al Products Ad­min­is­tra­tion ("NMPA") is­sued the Ad­min­is­trat­ive Pro­vi­sions on Drug An­nu­al Re­port­ing (“Pro­vi­sions”) on 11 April 2022, which took ef­fect on the same day. The Pro­vi­sions...